Together, these findings demonstrate that DDX3 drives a metabolic shift toward FAO in metastatic breast cancer cells by promoting mitochondrial fission and maintaining mitochondrial function under lipid-rich conditions, supporting the notion that DDX3 contributes to metabolic reliance on FAO in metastatic contexts. This evidence concerns the gene DDX3X and breast cancer.